drugset / Trial / NCT00153140

Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation

NCT00153140

Phase 4 Completed 239 enrolled Braintree Laboratories
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the safety and efficacy of extended polyethyleneglycol3350 use to tegaserod in patients with chronic constipation.

Timeline

Start
2004-07
Primary completion
2004-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject polyethylene glycol Other / unclassified 17 g

Indications